Insulin modulates gluconeogenesis by inhibition of the coactivator TORC2

Renaud Dentin, Yi Liu, Seung Hoi Koo, Susan Hedrick, Thomas Vargas, Jose Heredia, John Yates, Marc Montminy

Research output: Contribution to journalArticlepeer-review

333 Citations (Scopus)


During feeding, increases in circulating pancreatic insulin inhibit hepatic glucose output through the activation of the Ser/Thr kinase AKT and subsequent phosphorylation of the forkhead transcription factor FOXO1 (refs 1-3). Under fasting conditions, FOXO1 increases gluconeogenic gene expression in concert with the cAMP responsive coactivator TORC2 (refs 4-8). In response to pancreatic glucagon, TORC2 is de-phosphorylated at Ser 171 and transported to the nucleus, in which it stimulates the gluconeogenic programme by binding to CREB. Here we show in mice that insulin inhibits gluconeogenic gene expression during re-feeding by promoting the phosphorylation and ubiquitin-dependent degradation of TORC2. Insulin disrupts TORC2 activity by induction of the Ser/Thr kinase SIK2, which we show here undergoes AKT2-mediated phosphorylation at Ser 358. Activated SIK2 in turn stimulated the Ser 171 phosphorylation and cytoplasmic translocation of TORC2. Phosphorylated TORC2 was degraded by the 26S proteasome during re-feeding through an association with COP1, a substrate receptor for an E3 ligase complex that promoted TORC2 ubiquitination at Lys 628. Because TORC2 protein levels and activity were increased in diabetes owing to a block in TORC2 phosphorylation, our results point to an important role for this pathway in the maintenance of glucose homeostasis.

Original languageEnglish
Pages (from-to)366-369
Number of pages4
Issue number7160
Publication statusPublished - 2007 Sept 20
Externally publishedYes

Bibliographical note

Funding Information:
Acknowledgements We thank R. Crystal for Ad-CRE-Luc and Ad-Rsv-Luc reporters. We also thank J. Meisenhelder for help with two-dimensional tryptic mapping and L. Vera for mouse tail vein injections. This work was supported by NIH grants. R.D. is a recipient of a post-doctoral fellowship from the Fondation pour la Recherche Médicale and is supported by the Bettencourt Schuller Foundation. Y.L. is a Hillblom Foundation Fellow. S.-H.K. was supported by a grant of the Korea Health 21 R&D Project, Ministry of Health & Welfare, Republic of Korea. M.M. is supported by the Keickhefer Foundation. This research was also supported in part by the Foundation for Medical Research, Inc.

ASJC Scopus subject areas

  • General


Dive into the research topics of 'Insulin modulates gluconeogenesis by inhibition of the coactivator TORC2'. Together they form a unique fingerprint.

Cite this